Publication | Open Access
Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase
111
Citations
12
References
2009
Year
The results from this retrospective analysis supported imatinib dose escalation as an appropriate initial option for patients with CML-CP who were experiencing suboptimal cytogenetic response or resistance.
| Year | Citations | |
|---|---|---|
Page 1
Page 1